CHP Perspective
From global innovation to regional adoption
A regional growth strategy starts with clinical relevance, implementation requirements and a credible route to market.
CHP's geographic strategy connects global innovation with a focus on the UAE, Saudi Arabia and the wider GCC. Our interest in technologies from Europe, North America and Asia-Pacific is grounded in a practical question: where could an innovation have a credible path to relevant, responsible deployment?
Our assessment therefore includes more than market size. We consider the intended care setting, clinical evidence, implementation needs, applicable regulatory and reimbursement pathways, and the partners required for commercialisation.
Regional relevance is not a badge that a technology receives automatically because it has succeeded elsewhere. Within our model, it is something to examine through evaluation, validation and implementation planning.
For founders and partners, the opportunity is to connect the strengths of a technology with a clear understanding of how it would reach users and create sustainable value. That is the regional lens we are building into CHP's investment approach.
A CHP Perspective sets out our own view on investing in health technology. It is not research, advice or a description of completed investment activity.